Translate Bio Insider Trades

0.00 (0.00 %)
(As of 09/14/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume34,832 shs
Average Volume1.67 million shs
Market Capitalization$2.82 billion
P/E Ratio66.71
Dividend YieldN/A

Translate Bio (NASDAQ:TBIO) Insider Buying and Selling Activity

9.40% of Translate Bio's shares are owned by company executives, directors and other insiders. Over the past twelve months, Translate Bio insiders have sold shares 4 time(s), totalling $24,428,780.00. Insiders that have sold shares include Owen Hughes, Paul D. Burgess, Ronald C. Renaud Jr., and Jean Francois Formela.

Insider Buying and Selling by Quarter

Translate Bio (NASDAQ TBIO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2021Owen HughesDirectorSell29,860$38.00$1,134,680.00  
9/14/2021Paul D. BurgessCOOSell71,833$38.00$2,729,654.00  
9/14/2021Ronald C. Renaud, Jr.CEOSell503,231$38.00$19,122,778.00  
12/21/2020Jean Francois FormelaDirectorSell56,536$25.50$1,441,668.00  
8/27/2020Jean Francois FormelaDirectorSell88,888$14.83$1,318,209.04
6/30/2020Human Genetic Therapies ShireMajor ShareholderSell6,824,992$20.68$141,140,834.56  
6/26/2020Baupost Group Llc/MaMajor ShareholderBuy500,000$22.00$11,000,000.00  
6/3/2020Human Genetic Therapies ShireMajor ShareholderSell40,086$19.75$791,698.50  
6/1/2020Human Genetic Therapies ShireMajor ShareholderSell108,472$19.86$2,154,253.92  
7/2/2018Brian M Jr. GallagherDirectorBuy269,230$13.00$3,499,990.00  
7/2/2018Mrl Ventures Fund LlcMajor ShareholderBuy25,000$13.00$325,000.00  
(Data available from 1/1/2013 forward)
speech bubbles
speech bubbles

Translate Bio (NASDAQ:TBIO) Insider Trade Frequently Asked Questions

Who is on Translate Bio's Insider Roster?

The list of insiders at Translate Bio includes Baupost Group Llc/Ma, Human Genetic Therapies Shire, Jean Francois Formela, Owen Hughes, Paul D. Burgess, and Ronald C. Renaud, Jr..Learn more on TBIO's insiders

What percentage of Translate Bio stock is owned by insiders?

9.40% of Translate Bio stock is owned by insiders. Learn more on TBIO's insider holdings

Which Translate Bio insiders have been buying company stock?

The following insider purchased Translate Bio stock in the last 24 months: Baupost Group Llc/Ma ($11,000,000.00).

How much insider buying is happening at Translate Bio?

Insiders have purchased a total of 500,000 Translate Bio shares in the last 24 months for a total of $11,000,000.00 bought.

Which Translate Bio insiders have been selling company stock?

The following insiders have sold Translate Bio stock in the last 24 months: Human Genetic Therapies Shire ($144,086,786.98), Jean Francois Formela ($2,759,877.04), Owen Hughes ($1,134,680.00), Paul D. Burgess ($2,729,654.00), and Ronald C. Renaud, Jr. ($19,122,778.00).

How much insider selling is happening at Translate Bio?

Insiders have sold a total of 7,723,898 Translate Bio shares in the last 24 months for a total of $169,833,776.02 sold.

This page was last updated on 9/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.